参考文献/References:
[1] Lu Y,Zhang Y,Chang G,et al.Compar ison of prostate-specific promoters and the use of psp-driven virotherapy for prostate cancer[J/OL].Biomed Res Int,2013,2013:624632[2013-12-01].http://www.ncbi.nlm.nih.gov/pubmed/23484134.
[2] Baiz D,Hassan S,Choi YA,et al.Combination of the PI3k inhibitor zstk474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancer[J].Neoplasia,2013,15(10):1172-1183.
[3] Claessens F,Rushmere NK,Davies P,et al.Sequence-specific binding of androgen-receptor complexes to prostatic binding protein genes[J].Mol Cell Endocrinol,1990,74(3):203-212.
[4] Kesmodel S,Prabakaran I,Canter R,et al.Virus-mediated oncoly-sis of thyroid cancer by a replication-selective adenovirus driven by a thyroglobulin promoter-enhancer region[J].J Clin Endocrinol Metab,2005,90(6):3440-3448.
[5] Spitzweg C,Baker CH,Bergert ER,et al.Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression[J].Hum Gene Ther,2007,18(10):916-924.
[6] Chen EQ,Song XQ,Wang YL,et al.Construction of a highly-ac-tive,liver-specific transcriptional regulatory element through com-bination of the albumin promoter and alpha-fetoprotein enhancer[J].Plasmid,2010,65(2):125-131.
[7] Horst M,Brouwer E,Verwijnen S,et al.Targeting malignant gliomas with a glial fibrillary acidic protein (GFAP)-selective on-colytic adenovirus[J].J Gene Med,2007,9(12):1071-1079.
[8] Li W,Tan J,Wang P,et al.The glial fibrillary acidic protein pro-moter directs sodium/iodide symporter gene expression for radioio-dine therapy of malignant glioma[J].Oncol Lett,2013,5(2):669-674.
[9] Tanaka M,Inase N,Miyake S,et al.Neuron specific enolase pro-moter for suicide gene therapy in small cell lung carcinoma[J].An-ticancer Res,2001,21(1A):291-294.
[10] Jin C,Yu D,?an?er M,et al.Tat-PTD-modified oncolytic aden-ovirus driven by the SCG3 promoter and ASH1 enhancer for neu-roblastoma therapy[J].Hum Gene Ther.2013,24(8):766-775.
[11] Peng YF,Shi YH,Ding ZB,et al.a-Fetoprotein promoter-driven Cre/Loxp-switched RNA interference for hepatocellular carcinoma tissue-specific target therapy[J/OL].PLoS One,2013,8(2):e53072.http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0053072
[12] Zhou X,Xie G,Wang S,et al.Potent and specific antitumor effect for colorectal cancer by CEAand Rbdouble regulated oncolytic adenovirus harboring ST13 gene[J/OL].PLoS One,2012,7(10):e47566.http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0047566.
[13] Qiu Y,Peng GL,Liu QC,et al.Selective killing of lung cancer cells using carcinoembryonic antigen promoter and double suicide genes,thymidine kinase and cytosine deaminase (pCEA-TK/CD)[J].Can-cer Lett,2012,316(1):31-38.
[14] Guo X,Evans TR,Somanath S,et al.In vitro evaluation of cancer-specific NF-kappaB-CEA enhancer-promoter system for 5-fluo-rouracil prodrug gene therapy in colon cancer cell lines[J].Br J Cancer,2007,97(6):745-754.
[15] Yi T,Papadopoulos E,Hagner PR,et al.Hypoxia-inducible factor-1a (HIF-1a) promotes cap-dependent translation of selective mR-NAs through up-regulating initiation factor eIFf4E1 in breast can-cer cells under hypoxia conditions[J].J Biol Chem,2013,288(26):18732-18742.
[16] Doloff JC,Jounaidi Y,Waxman DJ.Dual E1A oncolytic aden-ovirus:targeting tumor heterogeneity with two independent can-cer-specific promoter elements,DF3/MUC1 and hTERT[J].Cancer Gene Ther,2011,18(3):153-166.
[17] Trujillo MA,Oneal MJ,Davydova J,et al.Construction of an MUC-1 promoter driven,conditionally replicating adenovirus that ex-presses the sodium iodide symporter for gene therapy of breast can-cer[J].Breast Cancer Res,2009,11(4):R53.
[18] Won YS,Lee SW.Cancer-specific induction of adenoviral E1A ex-pression by group Iintron-based trans-splicing ribozyme[J].J Mi-crobiol Biotechnol,2012,22(3):431-435.
[19] Rajecki M,Sarparanta M,Hakkarainen T,et al.SPECT/CT imaging of hNIS-expression after intravenous delivery of an oncolytic aden-ovirus and 131I[J/OL].PLoS One,2012,7(3):e32871.http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0032871.
[20] Li W,Tan J,Wang P,et al.Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase re-verse transcriptase promoter for targeted radioiodine therapy of ma-lignant glioma cells[J].Cancer Biother Radiopharm,2011,26(4):443-451.
[21] Chen J,Yang B,Zhang S,et al.Antitumor potential of SLPI pro-moter controlled recombinant caspase-3 expression in laryngeal carcinoma[J].Cancer Gene Ther,2012,19(5):328-335.
[22] Maemondo M,Saijo Y,Narumi K,et al.Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer[J].Cancer Res,2004,64(13):4611-4620.
[23] Barker SD,Coolidge CJ,Kanerva A,et al.The secretory leukopro-tease inhibitor (SLPI) promoter for ovarian cancer gene therapy[J].J Gene Med,2003,5(4):300-310.
[24] Niu Y,Li JS,Luo XR.Enhancement of expression of survivin pro-moter-driven CD/TK double suicide genes by the nuclear matrix at-tachment region in transgenic gastric cancer cells[J].Gene,2014,534(2):177-182.
[25] 严泽军,程跃,蒋军辉,等.Survivin启动子调控腺病毒介导富含亮氨酸重复和免疫球蛋白样结构域1基因治疗膀胱癌的实验研究[J].中华外科杂志,2012,50(8):732-736.
[26] Liu C,Sun B,An N,et al.Inhibitory effect of Survivin promoter-regulated oncolytic adenovirus carrying P53 gene against gallblad-der cancer[J].Mol Oncol,2011,5(6):545-554.
[27] Xiang J,Ouyang Y,Cui Y,et al.Silencing of notch3 using shRNA driven by survivin promoter inhibits growth and promotes apoptosis of human T-cell acute lymphoblastic leukemia cells[J].Clin Lym-phoma Myeloma Leuk,2012,12(1):59-65.
[28] Ma J,Li M,Mei L,et al.Double suicide genes driven by kinase do-main insert containing receptor promoter selectively kill human lung cancer cells[J].Genet Vaccines Ther,2011,9:6.
[29] Li XH,Zhou P,Wang LH,et al.The targeted gene (KDRP-CD/TK) therapy of breast cancer mediated by SonoVue and ultrasound irra-diation in vitro[J].Ultrasonics,2012,52(1):186-191.
[30] 马晓方,杜晓光,辛现良,等.肿瘤细胞恶性增殖和细胞周期调控改变的分子机制[J].现代生物医学进展,2009,9(5):950-953.
[31] Sherr CJ,McCormick F.The RB and p53 pathways in cancer[J].Cancer Cell,2002,2(2):103-112.
[32] Yan Y,Xu Y,Zhao Y,et al.Combination of E2F-1 promoter-regu-lated oncolytic adenovirus and cytokine-induced killer cells en-hances the antitumor effects in an orthotopic rectal cancer model[J].Tumour Biol,2013:35(2):1113-1122.
[33] Lin G,Lin MC,Lin S,et al.Early growth response protein-1 pro-moter-mediated synergistic antitumor effect of hTERTC27 gene therapy and 5-Flurorouracil on nasopharyngeal carcinoma[J].Can-cer Biother Radiopharm,2013,27(7):434-441.
[34] Rein DT,Volkmer A,Beyer IM,et al.Treatment of chemotherapy resistant ovarian cancer with a MDR1 targeted oncolytic adenovirus[J].Gynecol Oncol,2011,123(1):138-146.
[35] Maeda T,O-Wang J,Matsubara H,et al.A minimum c-erbb-2 pro-moter-mediated expression of herpes simplex virus thymidine ki-nase gene confers selective cytotoxicity of human breast cancer cells to ganciclovir[J].Cancer Gene Ther,2001,8(11):890-896.
[36] Nettelbeck DM,Jerome V,Muller R.Gene therapy:designer pro-moters for tumour targeting[J].Trends Genet,2000,16(4):174-181.
[37] Yu B,Zhang Y,Zhan Y,et al.Co-expression of herpes simplex virus thymidine kinase and Escherichia coli nitroreductase by an hTERT-driven adenovirus vector in breast cancer cells results in additive anti-tumor effects[J].Oncol Rep,2011,26(1):255-264.
[38] 李玮,谭建,王澎,等.hTERT和GFAP启动子条件限制腺病毒介导放射性碘治疗脑胶质瘤[J].中华放射医学与防护杂志,2014,34(1):1-6.
相似文献/References:
[1]王芹,王敬敏,徐畅,等.Ad-Rb94联合照射对体外人大肠癌细胞的抑瘤作用[J].国际放射医学核医学杂志,2014,38(6):351.[doi:10.3760/cma.j.issn.1673-4114.2014.06.001]
Wang Qin,Wang Jing-min,Xu Chang,et al.The effect of Ad-Rb94 combined with radiation on inhibiting the growth of human colorectal cancer cells in vitro[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(3):351.[doi:10.3760/cma.j.issn.1673-4114.2014.06.001]
[2]王芹,刘晓秋,李进,等.白细胞介素21基因联合不同剂量γ射线照射对乳腺癌细胞生长的影响[J].国际放射医学核医学杂志,2012,36(2):94.[doi:10.3760/cma.j.issn.1673-4114.2012.02.009]
WANG Qin,LIU Xiao-qiu,LI Jin,et al.Effects of interleukin-21 gene combined with different doses of γ-ray radiation on growth of breast carcinoma cells[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(3):94.[doi:10.3760/cma.j.issn.1673-4114.2012.02.009]
[3]石朔,李彪.促血管生成因子在治疗缺血性心脏病中的应用[J].国际放射医学核医学杂志,2013,37(6):355.[doi:10.3760/cma.j.issn.1673-4114.2013.06.008]
SHI Shuo,LI Biao.Utility of the angiogenesis factors in the management of ischemic heart disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(3):355.[doi:10.3760/cma.j.issn.1673-4114.2013.06.008]
[4]郭睿,李彪.早期生长反应基因1启动子介导肿瘤基因-放疗的研究进展[J].国际放射医学核医学杂志,2010,34(4):206.[doi:10.3760/cma.j.issn.1673-4114.2010.04.004]
GUO Rui,LI Biao.The progress of tumor gene-radiotherapy induced by Egr-1 promoter[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(3):206.[doi:10.3760/cma.j.issn.1673-4114.2010.04.004]
[5]陈凤华,李进,谭志军,等.Ad-Rb94联合γ射线照射对食管癌细胞生长的影响[J].国际放射医学核医学杂志,2010,34(2):119.[doi:10.3760/cma.j.issn.1673-4114.2010.02.017]
CHEN Feng-hua,LI Jin,TAN Zhi-jun,et al.Effects of recombinant adenovirus mediated retinoblastoma gene 94 combined with γ-ray on growth of esophageal carcinoma cells[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(3):119.[doi:10.3760/cma.j.issn.1673-4114.2010.02.017]
[6]郭睿,李彪.钠碘同向转运体基因介导放射性碘治疗肿瘤的研究进展[J].国际放射医学核医学杂志,2010,34(3):147.
GUO Rui,LI Biao.Advances of radioiodine therapy of tumor induced by sodium iodide symporter gene[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(3):147.
[7]翟红彦,苏成海.基因治疗联合放射治疗恶性肿瘤的分子机制[J].国际放射医学核医学杂志,2009,33(2):113.[doi:10.3760/cma.j.issn.1673-4114.2009.02.015]
ZHAI Hong-yan,SU Cheng-hai.Molecular mechanism of genetherapy combined radiotherapy for malignant tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(3):113.[doi:10.3760/cma.j.issn.1673-4114.2009.02.015]
[8]方圣伟,奚望,张宏.分子核医学的发展和应用前景[J].国际放射医学核医学杂志,2009,33(6):321.[doi:10.3760/cma.j.issn.1673-4114.2009.06.001]
FANG Sheng-wei,XI Wang,ZHANG Hong.The developments and applications of molecular nuclear medicine[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(3):321.[doi:10.3760/cma.j.issn.1673-4114.2009.06.001]
[9]张国鹏,张永学.心肌缺血性疾病基因治疗及分子影像监测进展[J].国际放射医学核医学杂志,2008,32(5):257.
ZHANG Guo-peng,ZHANG Yong-xue.Advances in gene therapy of myocardial ischemia and the monitoring with molecular imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(3):257.
[10]张俊,刘增礼.钠碘转运体基因介导的肿瘤放射性核素治疗研究[J].国际放射医学核医学杂志,2008,32(1):8.
ZHA NG Jun,LIU Zeng-li.Sodium iodide symporter gene-mediated radionuclide therapy of tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(3):8.